KaloBios Pharmaceuticals Inc – (NASDAQ:KBIO)

Just a day after KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) announced that they had appealed the Nasdaq’s decision to delist their stock, we’ve just become aware that…

Although shareholders of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) remain in limbo without their CEO and most of their board, a little bit of good news came…

As if things couldn’t get any worse for KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) shareholders after it was announced earlier in the day that the company would…

Although shares of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) are still halted by the NASDAQ following the arrest of former CEO Martin Shkreli, investors may be in…

Although there has been plenty of news for shareholders of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) to digest, none of them have been able to act on…

As KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) shareholders anxiously and hesitantly wait for the NASDAQ to lift the halt on the stock, the company’s CEO Martin Shkreli…

KaloBios Pharmaceuticals’ (NASDAQ:KBIO) trial for a leukemia drug called KB003 has been suspended by the University of California at Davis and Moffitt Cancer Center in…

While KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) shareholders continue to wait on the NASDAQ to lift the current halt on shares, news has just broke that certainly…

As you all likely know by now, shares of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) have been halted by the NASDAQ folowing the news that the company’s…

As we’ve mentioned earlier today, shares of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) were down over 50% in pre-market trading after the company’s CEO Martin Shkreli was…

Shares of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) are down over 50% in pre-market trading this morning as their savior CEO Martin Shkreli was arrested on securities…